FRANKFURT, Jan 30 (Reuters) - Swiss drugs and diagnostics company Roche ROG.S said on Thursday it is targeting an increase in core 2025 earnings per share in a high single-digit percentage range, when adjusted for currency swings.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.